Regeneron Pharmaceuticals (REGN) Stock Chart & Stock Price History $605.61 +15.61 (+2.65%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$605.30 -0.31 (-0.05%) As of 04:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Regeneron Pharmaceuticals Stock Price Performance 5 Day Performance+6.45%1 Month Performance+5.61%3 Month Performance-13.12%6 Month Performance-26.93%Year-To-Date Performance-14.98%1 Year Performance-36.72% Receive REGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address REGN Stock Chart for Monday, May, 5, 2025 REGN Chart by TradingView Regeneron Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025$590.00$605.61+2.65%$615.61$599.081.61 million shs$66.21 billion05/01/2025$598.76$590.00-1.46%$593.94$578.501.19 million shs$64.50 billion04/30/2025$568.91$598.76+5.25%$600.20$566.991.68 million shs$65.46 billion04/29/2025$610.86$568.91-6.87%$579.98$542.442.62 million shs$62.20 billion04/28/2025$602.64$610.86+1.36%$614.83$601.191.18 million shs$66.78 billion04/25/2025$599.76$602.64+0.48%$602.79$585.78964,377 shs$65.88 billion04/24/2025$587.85$599.76+2.03%$601.28$586.811.32 million shs$65.57 billion04/23/2025$585.49$587.85+0.40%$603.77$584.45791,840 shs$64.27 billion04/22/2025$561.49$585.49+4.27%$587.10$565.14981,554 shs$64.01 billion04/21/2025$563.16$561.49-0.30%$570.35$552.97698,384 shs$61.38 billion Get the Latest News and Ratings for REGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025$563.16$563.16$564.21$545.00827,663 shs$61.57 billion04/17/2025$549.28$563.16+2.53%$564.21$545.00827,663 shs$61.57 billion04/16/2025$557.91$549.28-1.55%$561.83$544.50875,684 shs$60.05 billion04/15/2025$571.06$557.91-2.30%$575.20$553.00838,226 shs$60.99 billion04/14/2025$554.18$571.06+3.05%$574.72$555.39946,327 shs$62.43 billion04/11/2025$546.39$554.18+1.43%$555.53$533.261.17 million shs$60.59 billion04/10/2025$576.72$546.39-5.26%$571.99$529.721.35 million shs$59.73 billion04/09/2025$556.81$576.72+3.58%$580.73$525.991.87 million shs$63.05 billion04/09/2025$556.81$576.72+3.58%$580.73$525.991.87 million shs$63.05 billion04/08/2025$572.78$556.81-2.79%$586.03$546.361.15 million shs$60.87 billion04/08/2025$572.78$556.81-2.79%$586.03$546.361.15 million shs$60.87 billion04/07/2025$573.45$572.78-0.12%$591.55$557.831.68 million shs$62.62 billion04/04/2025$610.64$573.45-6.09%$612.99$572.001.55 million shs$62.69 billion04/03/2025$625.60$610.64-2.39%$628.00$607.881.05 million shs$66.76 billion Related Companies Amgen Stock Price Chart Gilead Sciences Stock Price Chart Vertex Pharmaceuticals Stock Price Chart Alnylam Pharmaceuticals Stock Price Chart Biogen Stock Price Chart United Therapeutics Stock Price Chart BioMarin Pharmaceutical Stock Price Chart Incyte Stock Price Chart Exelixis Stock Price Chart Neurocrine Biosciences Stock Price Chart Receive REGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:REGN) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy REGN Stock Free REGN Stock Alerts